Compromiso pulmonar en síndrome de Sjögren / Pulmonary involvement in Sjögren's syndrome
Rev. colomb. reumatol
; 27(supl.2): 109-124, oct.-dic. 2020. tab, graf
Article
in Spanish
| LILACS
| ID: biblio-1341346
Responsible library:
CO356.9
RESUMEN
RESUMEN El síndrome de Sjögren es una enfermedad autoinmunitaria sistémica con un alto impacto individual y social. El compromiso pulmonar presenta múltiples manifestaciones, con impacto en calidad de vida y riesgo de mortalidad. El abordaje dinámico integrado mediante un grupo de diagnóstico multidisciplinario que incluya expertos en neumología, reumatología, radiología y patología tiene el potencial de impactar en la identificación, las estrategias de manejo y los desenlaces. Aunque es necesario reconocer tempranamente a los pacientes con mayor riesgo, en la actualidad no se cuenta con biomarcadores confiables. Las estrategias de manejo farmacológico se basan en la inmunomodulación, pero la evidencia para su uso es de baja calidad. Promover el entrenamiento y la sensibilización del personal de salud podría reducir los retrasos en el acceso a una evaluación especializada.
ABSTRACT
ABSTRACT Sjögren's syndrome is a systemic autoimmune disease with a high burden for the individual, as well as society. Pulmonary compromise presents with a myriad of manifestations that influence patient quality of life and mortality risk. An integrated dynamic approach by a multidisciplinary diagnostic discussion team that includes experts in chest diseases, rheumatology, radiology, and pathology has the potential to improve the identification, management strategies, and outcomes. Although early recognition of patients at high risk is essential, there is currently a lack of reliable biomarkers. Pharmacological therapies are based on immunomodulation, although the evidence to support their use is of low quality. Increasing awareness and training among healthcare professionals may reduce a delayed access to specialized assessment.
Full text:
Available
Collection:
International databases
Health context:
SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases
Health problem:
Immune Disorders
/
Musculoskeletal Diseases and Rheumatic Disorders
/
Sense Organ Diseases
Database:
LILACS
Main subject:
Sjogren's Syndrome
/
Lung
Type of study:
Diagnostic study
/
Prognostic study
Aspects:
Patient-preference
Limits:
Humans
Language:
Spanish
Journal:
Rev. colomb. reumatol
Journal subject:
Rheumatology
Year:
2020
Document type:
Article
Affiliation country:
Colombia
Institution/Affiliation country:
Pontificia Universidad Javeriana/CO